Anaptysbio Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$69.33

+2.37 (+3.54%)

As of May 10, 10:08 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 89%

Hold 2 11%

Sell 0 0%

Price Target

Analyst Price Target -25.3% upside

Low Target $39.42

Average Target $51.79

High Target $66.87

Current Price $69.33

Current
$69.33

Target
$51.79

$39.42 $51.79 avg $66.87

Scenario Analysis

Bear Case

$39.42

-43.1%

Low target

Base Case

$51.79

-25.3%

Avg target

Bull Case

$66.87

+-3.5%

High target

Risk/Reward

0.1x

Unfavorable

Price in Context

52-Week High

$73.30

-5.4% from high

52-Week Low

$17.11

+305.3% from low

Target vs 52W High

$51.79

-29.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%